Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-052497
Filing Date
2025-05-23
Accepted
2025-05-23 17:06:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 11029
  Complete submission text file 0001104659-25-052497.txt   12685
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Subject) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-91969 | Film No.: 25983303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIREO GROWTH INC. 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address
Jeffery Christopher (Filed by) CIK: 0002069637 (see all company filings)

Type: SCHEDULE 13D